Dexmedetomidine protects against degeneration of dopaminergic neurons and improves motor activity in Parkinson's disease mice model

Parkinson’s disease (PD) is the result of dopaminergic (DA) neuronal death in the substantianigra pars compacta (SNc). Current treatments for PD such as L-dopa are limited in effectiveness and fail to address the cause. Targeted anti-inflammatory therapies, particularly directed at nuclear factor ka...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bao-ping, Wu, Li, Wu, Xian-wei, Wang, Fang, Zhao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176059/
https://www.ncbi.nlm.nih.gov/pubmed/34121856
http://dx.doi.org/10.1016/j.sjbs.2021.04.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176059/
https://www.ncbi.nlm.nih.gov/pubmed/34121856
http://dx.doi.org/10.1016/j.sjbs.2021.04.013

Ejemplares similares